Patients with cancer pain comprise the second large population placed at risk by stigmatizing NSAID use. The World Health Organization method for cancer pain relief is based upon a three-step "ladder" in which the first step is an NSAID. Steps two and three involve addition of weak or strong opioids, respectively, when pain is poorly controlled.
in which adverse events such as myocardial infarction have been monitored prospectively in many thousands of patients given brief (<1 week) courses of NSAIDs. Patients with cancer pain comprise the second large population placed at risk by stigmatizing NSAID use. The World Health Organization method for cancer pain relief is based upon a three-step "ladder" in which the first step is an NSAID. Steps two and three involve addition of weak or strong opioids, respectively, when pain is poorly controlled.
The efficacy and population-based effectiveness of this strategy have been confirmed in numerous clinical studies, and it is the foundation for palliative care pharmacotherapy worldwide. At least part of the benefit of this method results from reduction of opioid requirements: the side effects of opioid therapy are often dose-limiting and commonly impair health-related quality of life in patients with cancer. 4 Examples of overgeneralization of pharmacoepidemiologic observations from one group to another, with consequent detriment to the public welfare, have been seen before. 
